Sigma-Aldrich, Inc.

St. Louis, MO Doing business as Sigma-Aldrich Sales, Inc.

UEI
WFYWL6SQ6FB8
CAGE
54968
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Cerilliant Corporation, ranks:

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
Show all 24
Corporate family
SAM.gov registration date
Physical address
3050 Spruce St, St. Louis, MO 63103, USA
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Consumer Discretionary
  2. Consumer Services
  3. Diversified Consumer Services
  4. Specialized Consumer Services
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $278,108
FY2025 -$533,328
FY2024 $1,835,782
FY2023 $316,504

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $244,396
2 Environmental Protection Agency $34,389

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
General Atomics RESEARCH & DEVELOPMENT AND FABRICATION OF INERTIAL CONFINEMENT FUSION (ICF) TARGETS FOR THE OFFICE OF RTD&E NA-11, EXPERIMENTAL SCIENCES NA-113 Chem,… 89233124CNA000365 $3,120
General Atomics RESEARCH & DEVELOPMENT AND FABRICATION OF INERTIAL CONFINEMENT FUSION (ICF) TARGETS FOR THE OFFICE OF RTD&E NA-11, EXPERIMENTAL SCIENCES NA-113 Chem,… 89233124CNA000365 -$5,973
General Atomics RESEARCH & DEVELOPMENT AND FABRICATION OF INERTIAL CONFINEMENT FUSION (ICF) TARGETS FOR THE OFFICE OF RTD&E NA-11, EXPERIMENTAL SCIENCES NA-113 Chem,… 89233124CNA000365 $5,896

Grant subawards

Prime recipient Prime award Amount Awarded
General Atomics OperatingSply&Equip DEFC0204ER54698 $37,090

Similar vendors

About the company

Sigma-Aldrich, Inc., doing business as Sigma-Aldrich Sales, Inc., is a foreign-owned, for-profit manufacturer of life science and specialty chemical products that operates as a prime contractor (99% of recent awards) supplying chemicals, biological materials, laboratory equipment, and reagents to civilian federal agencies on a full-and-open basis with no set-aside designations. The vendor is headquartered in St. Louis, Missouri and is a subsidiary of parent company Sigma-Aldrich Corporation, which also owns Bioreliance Corporation, Cell Marque Corp, and Cerilliant Corporation—each with distinct manufacturing and life science capabilities.

Sigma-Aldrich's federal footprint centers on NIH institutes and related civilian research agencies. The top five customer agencies by award count account for 34% of recent awards, led by the Office of Logistics and Acquisition Operations (44 awards, $50.5 million combined potential value), followed by the National Institute of Allergy and Infectious Diseases (34 awards, $519 thousand), CDC Pittsburgh (29 awards, $1.5 million), the Navy Bureau of Medicine and Surgery (28 awards, $496 thousand), and the National Cancer Institute (27 awards, $394 thousand). By potential value, the Office of Logistics and Acquisition Operations dominates at $50.5 million across 44 awards, reflecting Sigma-Aldrich's position as a critical supplier under a $50 million single-award BPA through October 31, 2026. The two rankings diverge sharply—OLAO's dollar concentration reflects a single large vehicle, while NIAID's volume reflects many smaller individual purchase orders. Across 75 distinct customer agencies, the vendor has generated 474 federal awards with combined potential value of $262.4 million, though only 4% of that potential value has been obligated to date.

Sigma-Aldrich's capability portfolio reflects a specialized manufacturer and distributor of high-specification research materials. Recent representative prime awards include a $500,000 firm fixed-price purchase order from the National Institute of Standards and Technology (February 2025) for manufacturing monoclonal antibody expressed from the NISTCHO cell, a $201,319 purchase order from NIST (March 2024) for organic chemicals supporting mass spectrometry research, a $149,455 purchase order from CDC Pittsburgh (February 2022) for well plates, a $136,105 purchase order from the National Cancer Institute (September 2022) for pyruvic-1-13C acid for clinical studies, a $131,367 purchase order from the National Center for Advancing Translational Sciences (August 2026) for a nuisance chemical matter library, and a $119,213 purchase order from the National Institute of Environmental Health Sciences (September 2022) for CRISPR knockout libraries. Smaller awards span stable isotope-labeled water, protein purification reagents, flag resin, bovine serum, SPME fibers, enzyme preparations, and specialized laboratory supplies and equipment. Nearly all awards are firm fixed-price purchase orders under 100-day or shorter performance windows, reflecting routine procurement of consumables and equipment for research operations.

Sigma-Aldrich holds two named federal IDVs. The primary vehicle is the $50 million single-award BPA with the Office of Logistics and Acquisition Operations (effective October 1, 2024 through October 31, 2026) covering chemicals, biological materials, and laboratory supplies, with 75 task orders generating $658 thousand in combined potential value. The second is a $315,000 single-award indefinite delivery contract with the Defense Health Agency / Medical Command (May 19, 2023 through May 18, 2028) for water isotope products, specifically 10-atom% 18O-labeled water for military nutrition division studies, with two delivery orders generated to date, each valued at $63,000. Sigma-Aldrich also operates on the Federal Supply Schedule GS07F068AA, with six recorded task orders generating $285 thousand.

Activity volume has remained relatively flat across the past five years—16 awards in 2022, declining to 9 awards in both 2025 and 2026 year to date. Recompete exposure in the next twenty-four months is minimal: only five awards with combined potential value of $743 thousand face ultimate completion within that window. In its subcontractor role, Sigma-Aldrich supplies chemicals, reagents, and gases to General Atomics on research and development and fabrication of inertial confinement fusion targets for the Office of Acquisition and Logistics (three sub-awards in 2025 and 2026) and received one sub-grant from General Atomics in August 2024 for operating supplies and equipment.

The vendor's federal award portfolio concentrates across manufacturing NAICS codes: Biological Product Manufacturing (except Diagnostic) anchors 161 awards, All Other Basic Organic Chemical Manufacturing (67 awards), All Other Miscellaneous Chemical Product Manufacturing (52 awards), Analytical Laboratory Instrument Manufacturing (41 awards), and In-Vitro Diagnostic Substance Manufacturing (22 awards). PSC concentration mirrors this profile, with Chemicals (189 awards), Laboratory Equipment and Supplies (111 awards), and Drugs and Biologicals (66 awards) dominating the procurement mix. Nearly all awards carry no small business set-aside and operate as competitive full-and-open procurements, reflecting Sigma-Aldrich's status as a large foreign-owned manufacturer competing without compliance overhead or small-business preferences.

Quick answers

Is Sigma-Aldrich, Inc. registered in SAM.gov?

Yes. Sigma-Aldrich, Inc.'s SAM.gov registration is active through May 1, 2027.

Which contract vehicles does Sigma-Aldrich, Inc. hold?

Sigma-Aldrich, Inc. holds a place on 1 federal contract vehicle: Swabs and Media in Support of COVID-19 Response.

How much has Sigma-Aldrich, Inc. received in federal contracts?

Federal contracts obligated $1,897,066 to Sigma-Aldrich, Inc. in fiscal years 2023 through 2027.

How does Sigma-Aldrich, Inc. rank among federal contractors?

Sigma-Aldrich, Inc.'s parent company, Cerilliant Corporation, ranked #41 in PSC 6810 and #77 in NAICS 325414 in FY2025.

What is Sigma-Aldrich, Inc.'s most recent federal award?

Sigma-Aldrich, Inc.'s most recent federal contract award is Ncats: supply: library of pharmacologically active compounds: n/a (75N98026P01704), from Office of Logisitics and Acquisition Operations (NIH), on September 21, 2026.

On GovTribe

See Sigma-Aldrich, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors